Alongside Deputy Prime Minister Heng Swee Keat, DPM Gan would provide a steady hand during the initial transition and help mentor the younger office-holders, said the then incoming prime minister.

He noted his longstanding relationships with “key personalities” among Singapore leaders, including the likes of Deputy Prime Minister Heng Swee Keat, who negotiated the Comprehensive Economic ...

During PM Wong’s absence, Deputy Prime Minister Heng Swee Keat will be the acting prime minister. Chin Soo Fang is senior correspondent at The Straits Times, covering topics such as community ...

In the race to bolster pipelines and drive growth, biopharma manufacturers are reexamining traditional practices and reimagining market research protocols. Biopharma business development and licensing ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

Mr Lim Hock Heng, vice-president and site director at ... a skilled workforce ready to have an impact on the rapidly growing biopharma sector and, ultimately, for patients worldwide.” ...

Phase 2 trial data will continue to be the name of the game when it comes to VC investments into biopharma in 2025, according to PitchBook. “In 2025, venture capitalists are expected to ...

The biopharma landscape is evolving rapidly, with changing funding dynamics, emerging therapies and licensing trends reshaping the industry. As regulatory pressures and market volatility persist, ...

For example, more than half of the biopharma executives Deloitte surveyed said their companies need to rethink their R&D and product development strategies over the next 12 months. Companies may ...

As Enter Via Laundry’s Helly Raichura recently told us, “People should be queuing up for Keat Lee’s food at Lagoon Dining … The honesty of the food is genius, the detailed house-made sauces and stocks ...

The detention of several AstraZeneca employees and eventually the company’s China president Leon Wang unsettled investors, fueling fears of a crackdown similar to the GSK scandal 10 years ago.

SAN FRANCISCO Jan 14 (Reuters) - Biogen (BIIB.O), opens new tab expects revenue from new launches to exceed its current sales by 2028 and does not feel the need to chase additional business ...